Diab-spot is a non-invasive test to identify people at risk for diabetes or pre-diabetes without overnight fasting, a blood draw, or waiting for a lab result.
The AGE Reader provides an immediate cardiovascular risk prediction in major chronic diseases such as diabetes, renal failure and cardiovascular disease.
Find a distributor in your country. If your country is not listed, please contact DiagnOptics for your enquiries: firstname.lastname@example.org
Prof. dr. Bruce Wolffenbuttel about Advanced Glycation Endproducts (AGEs) and the search for AGE breaking or AGE lowering drugs. ......» read more
The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or DiagnOptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.